Light chain (AL) amyloidosis is a rare plasma cell dyscrasia. An estimated 12,000 people
live with the disease in the United States. AL amyloidosis occurs from the misfolding of …

Light chain (AL) amyloidosis is a disease in which malignant plasma cell clones affect
multiple organs including the heart and kidney. The mechanism for organ function …

Light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by the pathologic
production of fibrillar proteins comprised of monoclonal light chains which deposit in tissues …

Light chain amyloidosis is a plasma–cell disorder with a poor prognosis. It is a progressive
condition, causing worsening pain, disability, and life-limiting complications involving …

Amyloid light chain (AL) amyloidosis is a protein conformational disease. AL amyloidosis
results from aggregation of misfolded proteins that are deposited in tissues as amyloid fibrils …

The systemic amyloidoses are a group of complex diseases caused by tissue deposition of
misfolded proteins that results in progressive organ damage. The most common type …

Introduction: Systemic light-chain (AL) amyloidosis is an infiltrative disorder associated with
an underlying plasma cells dyscrasia, in which monoclonal immunoglobulin light chains …

AL amyloidosis is a plasma cell disorder leading to the production and extracellular
deposition of abnormal immunoglobulin light chains called amyloid. The pathogenesis of the …

Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …

Systemic light chain (AL) amyloidosis is a protein misfolding disorder characterized by the
deposition of abnormal immunoglobulin light chains in fibrillary aggregates, resulting in end …